Prof. Patrick Tan is the Executive Director of the Genome Institute of Singapore and Professor at Duke‐NUS Medical School Singapore. He is a Senior Principal Investigator at the Cancer Science Institute of Singapore and Executive Director of PRECISE (Precision Health Research Singapore), a business unit under the Ministry of Health coordinating the nation’s National Precision Medicine program.

During the 2020 COVID‐19 pandemic, he was Program Director of Operation Stronghold, establishing one of Singapore’s largest COVID‐19 testing facilities through a joint effort involving A*STAR (Agency for Science, Technology and Research), National University Health System, and Temasek Holdings.

He received his B.A. (summa cum laude) from Harvard University and MD PhD degree from Stanford University, where he received the Charles Yanofsky prize for Most Outstanding Graduate Thesis in Physics, Biology or Chemistry. Other awards include the President’s Scholarship, Loke Cheng Kim scholarship, Young Scientist Award (A‐STAR), Singapore Youth Award (twice), Chen New Investigator Award (Human Genome Organization), President’s Science Award, and the Japanese Cancer Association International Award. In 2018, he received the American Association for Cancer Research (AACR) Team Science Award as Team Leader, representing the first time a team from Asia has received the award.

He is an elected member of the American Society for Clinical Investigation (ASCI), the Bioethics Advisory Committee (BAC), a Board Member of the International Gastric Cancer Association, and on the Board of Reviewing Editors for Science.